tirzepatide surmount 2 once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURMOUNT 2 offers new data

Weekly weighing and monthly circumference or body-composition checks show trends beyond the scale, while simple strength tests (push-ups, squats, grip) quantify functional gains and flag muscle loss

(1-3) Its active ingredient, semaglutide, is also used in Wegovy, which the FDA has approved for treating obesity

In the Phase 2 trial published in the New England Journal of Medicine (2023), retatrutide was administered as a once-weekly subcutaneous injection using a structured dose-escalation schedule

Fast delivery but reordering was difficult The shipping for my order was incredibly fast, which I appreciated, but the reordering process on the site felt a bit clunky this time around

However, if you happen to be like most mere mortals and find yourself tempted beyond restraint in those days and weeks leading up to competition day, semaglutide could be the solution to keeping on track